Principal Investigator
Roberto Iacovelli, Prof
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(2)
DIAGNOSTIC_TEST(1)
Avelumab first-line maintenance
1 trial
phase_4
fondazione-policlinico-universitario-agostino-gemelli-irccsNGS test for DDR alterations
1 trial
phase_4
fondazione-policlinico-universitario-agostino-gemelli-irccsPlatinum + Gemcitabine
1 trial
phase_4
fondazione-policlinico-universitario-agostino-gemelli-irccs3 unique interventions2 categories
Analytics
Trial Phases
Phase 41
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUpper Tract Urothelial Cancer
PrincipalinvestigatorStart date: 2025-01-07
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
5 similar investigators found
Shih-Chieh Chueh
National Taiwan University Hospital
1 trials
Shared therapeutic areas:
Upper Tract Urothelial Cancer
Similarity Score10%
Jeremy Yuen-Chun TEOH, FRCS(Ed) MBBS
Chinese University of Hong Kong
1 trials
Shared therapeutic areas:
Upper Tract Urothelial Cancer
Similarity Score10%
Michael Abern, MD
Duke University
1 trials
Shared therapeutic areas:
Upper Tract Urothelial Cancer
Similarity Score10%
Jimmy Liu Zhao, MD, PhD
SystImmune Inc.
1 trials
Shared therapeutic areas:
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Similarity Score10%
Dr. Sandy Srinivas
Stanford University
11 trials
Shared therapeutic areas:
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Similarity Score10%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUpper Tract Urothelial Cancer
All 1 trials loaded